Allergan results turn up the heat on Valeant

Allergan’s better-than-expected second-quarter results turn up the heat on would-be suitor Valeant Pharmaceuticals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.